Research Supports Specific Blend of Green Teas Fight Cancer

NEW YORK - April 6, 2018 - PRLog -- The results of a new study comparing the anti-cancer effects of several well-known teas has shown a newly developed blend of green teas was superior at inhibiting the growth of two breast cancer cell lines, including one highly metastatic cell line.

A hand-written note stating "Tres, Tres (Very, Very) anti-C" next to four specific teas by the late Dr. Mirko Beljanski was discovered by The Beljanski Foundation. This note was the catalyst to take the next step and test the activity of these four green teas against human breast cancer cells. Green teas had long been associated with anti-oxidant benefits, but Dr. Beljanski subjected these four specific teas to his famous Oncotest, which was a method used to screen substances for carcinogenic and anti-carcinogenic potential of various molecules based on their effect on DNA stability. Could a modern-day laboratory prove Beljanski's results? Could the blend of four-green teas help fight breast cancer?

When tested against other teas including Bigelow®, Kusmi®, and Lipton®, the four-green tea blend (OnkoTea®) had the most potent anti-cancer effect on in vitro breast cancer cells. Data in the figure below shows the viability of the breast cancer cell lines after exposure to extracts of the teas tested (400 micrograms/ml). The green tea blend (OnkoTea®) was the best at reducing the number of two breast cancer cells, including metastatic cells.

The Beljanski Foundation continues to expand its research in order to find a natural, non-toxic cure for cancer. This most recent study, on the impact of specific teas on cancer, is another example of the groundbreaking work The Beljanski Foundation is doing.

The Beljanski Foundation is a 501 (c)(3) non-profit organization to help fund anti-cancer research to cure cancer the natural way. For more information please visit https://www.beljanski.org/engl/breast-cancer or email info@beljanski.org